POOL vs TBPH · P/E 18, rev $5.31B vs P/E 7.5, rev $18.8M
Pool Corporation (POOL) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Latest reported TBPH revenue for 2024-12-31 was $18.8M. Net income was -$15.5M. Revenue was up 11.2% from 2024-09-30 to 2024-12-31. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
POOL currently screens at market cap $7.08B and trailing P/E 17.9. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the POOL and TBPH stock pages for the full models.
Not investment advice.